Charite University, Berlin, Germany: Sclerosis trials
The registry lists 26 Sclerosis studies with Charite University, Berlin, Germany as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 10Phase 3 1No phase 16(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Neurofilament Light Chain in Amyotrophic Lateral SclerosisRecruitingNCT06201650
- Pregnancy Cohort in Multiple Sclerosis (MS)RecruitingNCT05010902
- The Influence of Extracorporeal Photopheresis on Skin SclerosisCompletedNCT04752397
- Nutritional Approaches in Multiple SclerosisStatus unknownNCT03508414Not applicable
- Online Program to Reduce Depression in MSCompletedNCT02740361Not applicable
- Depression and Immune Function in Multiple Sclerosis (MS)CompletedNCT02740296
- Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-studyCompletedNCT02695394
- Normobaric Hypoxic Training and Multiple SclerosisCompletedNCT02509897Not applicable
- Acupuncture or MBSR for Patients With Fatigue and MSCompletedNCT01864707Not applicable
- Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With FingolimodTerminatedNCT01790269
- A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple SclerosisCompletedNCT01538355Not applicable
- Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS)TerminatedNCT01440062Phase 2
- Metabolic Effects of a Green Tea Extract in Multiple Sclerosis PatientsCompletedNCT01417312Not applicable
- Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated SyndromeTerminatedNCT01413243Phase 2
- Cohort Study of Clinically Isolated Syndrome and Early Multiple SclerosisStatus unknownNCT01371071
- Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral SclerosisCompletedNCT01277315Phase 2
- Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple SclerosisCompletedNCT01272596
- Repetitive Deep Transcranial Magnetic Stimulation in Multiple SclerosisCompletedNCT01106365Not applicable
- The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00946738Not applicable
- Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00876772Phase 2/3
- Sildenafil for Treatment of Digital Ulcers in Patients With Systemic SclerosisCompletedNCT00624273Phase 2
- Flupirtine as Oral Treatment in Multiple SclerosisTerminatedNCT00623415Phase 2
- Effect of Different Iloprost Doses on Symptoms in Systemic SclerosisTerminatedNCT00622687Phase 2
- Atorvastatin in Relapsing-Remitting Multiple SclerosisCompletedNCT00616187Phase 2
- Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)CompletedNCT00525668Phase 1/2
- Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT00231140Phase 2